You can download the final program here
The International Society for Applied Cardiovascular Biology (ISACB) was founded in 1987 and is devoted to improve the quality of basic and applied research in all areas of cardiovascular biology, enhance communication between basic scientists, industry scientists and clinicians involved in these disciplines throughout the world and provide a forum of meetings featuring presentations of original work and topical reviews relevant to basic applied and clinical science of the cardiovascular system in health and disease.
This year ISACB is organizing a European meeting in Nuremberg, Germany. This meeting is focusing on bridging the gap between bench science and clinical practice. Topics are: Novel device therapies, novel cardiovascular biomaterials, potential failure mechanisms of therapies, new heart valve technologies, new drugs in cardiovascular therapy, atherosclerosis, endothelial protection, tissue degeneration, prospects (legal and scientific) of tissue engineering. Top class specialists will give key note lectures on latest results in the cardiovascular field. Keynote speakers include:
Francois Laborde, Paris: “Challenges in preclinical validation of TAVI, a glimpse on the future”
Stephan Nees, Munich: “The vascular wall and its diseases in the light of new cell biological findings”
Gaetano Thiene, Padua: “Tissue degeneration”
Simon Hoerstrup, Zurich: “Evolution of tissue engineered heart valves”
Peter Zilla, Cape Town: “The Challenge of Heart Surgery in the Third World: Tailor-made Innovations rather than imported First-World Technologies”
We encourage all colleagues working in these fields to take actively part in this unique Meeting. Please contact us for further details.
Theodor Fischlein MD
Head of Department , Cardiac Surgery
Paracelsus medical university
Johann Meinhart PhD
Deputy Director of the Karl Landsteiner Institute
for Cardiovascular Surgical Research